ROS1 tyrosine kinase inhibitors
DBCAT005903Pharmacologic class
A DrugBank category of 7 drugs. 7 of them are approved.
- Part of
- Tyrosine Kinase Inhibitors
What you can answer from here — as of February 22, 2024
Which targets do ROS1 tyrosine kinase inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account